French Oncologist: Alternative Smoking Reduces Mortalities but Still Harmful

An international expert in medical oncology said the concerned organizations should adopt a more realistic approach to banish smokers from cigarettes. AP
An international expert in medical oncology said the concerned organizations should adopt a more realistic approach to banish smokers from cigarettes. AP
TT

French Oncologist: Alternative Smoking Reduces Mortalities but Still Harmful

An international expert in medical oncology said the concerned organizations should adopt a more realistic approach to banish smokers from cigarettes. AP
An international expert in medical oncology said the concerned organizations should adopt a more realistic approach to banish smokers from cigarettes. AP

The World Health Organizations (WHO) estimates that there are around one billion smokers worldwide, a number that is not expected to decline in the foreseeable future and will likely remain steady until 2025.

An international expert in medical oncology said the concerned organizations should adopt a more realistic approach to banish smokers from cigarettes using an effective scientific methodology.

Dr. David Khayat, a renowned professor of oncology and medical oncologist in France, told Asharq Al-Awsat that “smoke-free alternatives could deliver a 10-fold reduction in smoking-attributable deaths; however, they are not harm free,” noting that “non-contagious diseases are the leading cause of death in the Middle East, accounting for 72 percent of mortalities.”

He also said “some common practices such as online shopping, regular dining in restaurants and humid weather encourage a lazy lifestyle.”

“The fundamental approach we adopted over the three past decades essentially relied on chemotherapy and hormone interventions. But the scientific research and innovation led us to advanced, more precise alternatives like the targeted therapy and immunotherapy,” he said. Khayat hailed “the discovery of another cancer-fighting treatment that targets the mutating proteins by killing the cells that contain them. These proteins are believed to be the reason behind the ability of endless division that some cancerous cells have.”

The French oncologist said “it’s important to know that cancer survives through mutations and single-cell DNA repair turnovers, which could be fought with targeted therapies,” adding that “other newly-discovered treatment methods, including stereotactic radiotherapy (or radiosurgery) help destroy tumors with high precision.”

The oncology professor said “in 2016, two researchers from Japan and the US discovered why cells sleep. Cancer is so malignant that it secretes somnifera - a sleeping pill - into the white blood cells, which causes them to go dormant. Then, scientists developed an innovative new approach: immunotherapy, a treatment method that contains antibiotic drugs to prevent lymphocytes from becoming inactive. This solution has changed the diagnosis of many cancers, including those found in the lungs, stomach and skin.”

“Nicotine, although addictive, is not the primary cause of smoking-related diseases such as cancer; smoking a cigarette means inhaling the smoke and the resulting burning ash, and this combustion process is the main reason behind many risks and toxins,” said Khayat.

Products that prevent combustion, such as electronic cigarettes, heated tobacco products and oral nicotine pouches, are “a less harmful alternative to conventional smoking.”

“While nicotine, the addictive substance, is still present in different levels in these alternatives, and thus does not make them completely risk-free, it is sufficient to shift smokers' interest away from inhaling cigarette smoke,” he concluded.



Japan Startup Hopeful Ahead of Second Moon Launch

Japan's Ryoyu Kobayashi soars through the air during the trial round of the Four Hills FIS Ski Jumping tournament (Vierschanzentournee), in Innsbruck, Austria on January 4, 2025. (Photo by GEORG HOCHMUTH / APA / AFP)
Japan's Ryoyu Kobayashi soars through the air during the trial round of the Four Hills FIS Ski Jumping tournament (Vierschanzentournee), in Innsbruck, Austria on January 4, 2025. (Photo by GEORG HOCHMUTH / APA / AFP)
TT

Japan Startup Hopeful Ahead of Second Moon Launch

Japan's Ryoyu Kobayashi soars through the air during the trial round of the Four Hills FIS Ski Jumping tournament (Vierschanzentournee), in Innsbruck, Austria on January 4, 2025. (Photo by GEORG HOCHMUTH / APA / AFP)
Japan's Ryoyu Kobayashi soars through the air during the trial round of the Four Hills FIS Ski Jumping tournament (Vierschanzentournee), in Innsbruck, Austria on January 4, 2025. (Photo by GEORG HOCHMUTH / APA / AFP)

Japanese startup ispace vowed its upcoming second unmanned Moon mission will be a success, saying Thursday that it learned from its failed attempt nearly two years ago.

In April 2023, the firm's first spacecraft made an unsalvageable "hard landing", dashing its ambitions to be the first private company to touch down on the Moon.

The Houston-based Intuitive Machines accomplished that feat last year with an uncrewed craft that landed at the wrong angle but was able to complete tests and send photos.

With another mission scheduled to launch next week, ispace wants to win its place in space history at a booming time for missions to the Moon from both governments and private companies.

"We at ispace were disappointed in the failure of Mission 1," ispace founder and CEO Takeshi Hakamada told reporters.

"But that's why we hope to send a message to people across Japan that it's important to challenge ourselves again, after enduring the failure and learning from it."

"We will make this Mission 2 a success," AFP quoted him as saying.

Its new lander, called Resilience, will blast off from Kennedy Space Center in Florida on January 15, along with another lunar lander built by US company Firefly Aerospace.

If Resilience lands successfully, it will deploy a micro rover and five other payloads from corporate partners.

These include an experiment by Takasago Thermal Engineering, which wants to split water into oxygen and hydrogen gas with a view to using hydrogen as satellite and spacecraft fuel.

- Rideshare -

Firefly's Blue Ghost lander will arrive at the Moon after travelling 45 days, followed by ispace's Resilience, which the Japanese company hopes will land on the Earth's satellite at the end of May, or in June.

For the program, officially named Hakuto-R Mission 2, ispace chose to cut down on costs by arranging the first private-sector rocket rideshare, Hakamada said.

Only five nations have soft-landed spacecraft on the Moon: the Soviet Union, the United States, China, India and, most recently, Japan.

Many companies are vying to offer cheaper and more frequent space exploration opportunities than governments.

Space One, another Japanese startup, is trying to become Japan's first company to put a satellite into orbit -- with some difficulty so far.

Last month, Space One's solid-fuel Kairos rocket blasted off from a private launchpad in western Japan but was later seen spiraling downwards in the distance.

That was the second launch attempt by Space One after an initial try in March last year ended in a mid-air explosion.

Meanwhile Toyota, the world's top-selling carmaker, announced this week it would invest seven billion yen ($44 million) in Japanese rocket startup Interstellar Technologies.

"The global demand for small satellite launches has surged nearly 20-fold, from 141 launches in 2016 to 2,860 in 2023," driven by private space businesses, national security concerns and technological development, Interstellar said.